What is black blood technology?
Black blood technology refers to a novel imaging technique that emerged in 2020, primarily utilized for examining the heart and brain. Most individuals are more familiar with nuclear magnetic resonance imaging (MRI), which is capable of visualizing various soft tissues, including muscles, ligaments, nerves, and brain structures. Traditional MRI relies on bright blood technology, which enhances blood signals while suppressing background noise to clearly delineate blood vessels. In contrast, magnetic resonance black blood imaging (MR-VWI) focuses on reducing or suppressing blood signals.
Why is a black blood test necessary?
A black blood test may be warranted if a carotid ultrasound reveals an increase in carotid plaque volume, stenosis of the carotid lumen exceeding 50%, or inadequate blood supply to the brain, particularly in the presence of early stroke symptoms such as dizziness, limb numbness, or syncope. Additionally, if CT angiography (CTA) or magnetic resonance angiography (MRA) identifies intracranial vascular stenosis or aneurysms, further evaluation through a series of tests will be conducted by the physician.
The primary advantage of carotid blood flow ultrasound is its affordability and ease of use, making it a standard method for community health screenings and assessments of cerebrovascular diseases. However, its limitations include a singular imaging perspective, as the probe only scans specific locations and cannot visualize all carotid arteries or those within the intracranial segment. Furthermore, operator-related technical factors can introduce inaccuracies in the results.
CTA involves radiation exposure and necessitates the injection of an iodine-based contrast agent. There is a potential risk of allergic reactions to the contrast agent, making it unsuitable for children and pregnant women. Nevertheless, the sensitivity of CTA is comparable to that of DSA (digital subtraction angiography). This method is non-invasive and is primarily utilized for preoperative assessments and postoperative evaluations of aneurysms.
MRA is capable of detecting abnormal vascular structures within the intracranial region, including the morphology of intracranial aneurysms, and can assess the vascular lumen. However, it does not provide information about the vascular wall. The quality of imaging can be significantly influenced by blood flow conditions, and the presence of various artifacts limits its reliability as a definitive diagnostic tool.
MR-VWI, or black blood imaging, allows for direct visualization of both the lumen and wall of the carotid artery, addressing the limitations of previous imaging techniques. It enhances clarity, minimizes artifacts, and emphasizes the vascular wall signals of intracranial aneurysms. This technology enables precise analysis of carotid and intracranial plaques, including their activity status. It assists healthcare professionals in evaluating vascular characteristics such as wall thickness, shape, and lesions, ultimately aiding in the assessment of rupture risk for intracranial aneurysms and facilitating the development of tailored treatment strategies.
Non-Ferrous Crucible Inc. offers a variety of medical raw materials, including marker bands, nitinol tubes, and nitinol wires, specifically designed for cardiovascular and cerebrovascular applications. Our products are known for their exceptional quality, competitive pricing, prompt service, and comprehensive selection. For further information, please visit our website.